A clear picture of the cost and efficacy of COVID-19 outpatient treatments
In a new study, RI-MUHC researchers have assessed all available outpatient therapies for COVID-19 to facilitate...
Unraveling the complexity of vitamin B12 diseases
Nature Communications study has implications for treatment of patients and genetic counselling
Cardiovascular care following a heart attack influenced by unemployment—and more so in the US than Canada, study suggests
New RI-MUHC study shows that health systems and unemployment influence...
A new understanding of mental illness
Three key factors might offer 90% accuracy in predicting wide range of psychiatric disorders
$2M to the MUHC Foundation for precision cancer care
BMO gift will help cancer researchers at the RI-MUHC develop the hospital’s precision oncology program
McGill team’s index predicts coma recovery with 100% accuracy
New Adaptive Reconfiguration Index has crucial implications for clinical management and decision-making in unconscious and unresponsive...
RI-MUHC research team leads new consortium to make healthcare data more accessible
The new Quebec SmartCare Consortium has received $10M to break down data silos and increase the...
FANCI: a new gene at the origin of some cases of ovarian cancer
For the first time, researchers link mutations in the FANCI gene to the risk of developing ovarian cancer
Multiplexed technologies are paving the way to rapid and equitable screening for sexually transmitted infections
Work by RI-MUHC postdoc Angela Karellis published in The Lancet...
Promising COVID-19 therapeutic drug to start phase 3 clinical trial in the United States
Recruitment of first U.S.-based patients in dapsone trial has started